Stock Attack II - A Complete Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Attack II - A Complete Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Captain Jack who wrote (16035)	8/20/2001 11:59:56 PM
From: jef saunders	Read Replies (1) of 52237

sales up 112% for my largest stock, dimethaid research. they started selling their arthritis drug (pennsaid) in england in april, and they had almost $1 million in sales in less than 2 months ! it was up over 12% today, 2nd day in a row that it gapped up: chart.canada-stockwatch.com ceo conference call had lots of good news coming up: * england agency whacked competitor drugs * canadian approval by december * 13 europe countries approval by december * fda plant inspection by december, u.s. approval to follow * nasdaq listing by june * results of phase 3 aids/cancer drug by december. by the way, it works. i've had the boat loaded on this for a long time, now the sales are taking off. c ya, jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next